Birdwatch Note Rating
2023-06-27 16:30:13 UTC - NOT_HELPFUL
Rated by Participant: EEB6D7CE737C51E08FE2D07807A8B6B932ADFA0043A6C860DD2879A5702F0EEB
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details